【第一百零九批】仿制药参比制剂目录序号药品通用名称英文名规格持证商备注1备注2剂型109-1普乐司兰钠注射液Plozasiran Sodium Injection/Redemplo（瑞达普）0.5 ml:25 mg（按C493H654F11N164O311P43S7计）Arrowhead Pharmaceuticals,Inc.国内上市的原研药品原研进口注射剂109-2注射用维替泊芬Verteporfin for injection/Visudyne15mgCHEPLAPHARM Arzneim...
2026/9/24 11:31:07
【第八十一批】仿制药参比制剂目录序号药品通用名称英文名规格持证商备注1备注2剂型81-1甲苯磺酸利特昔替尼胶囊Ritlecitinib TosylateCapsules/乐复诺50mg（按C15H19N5O 计）Pfizer Inc.国内上市的原研药品原研进口胶囊剂81-2硝酸咪康唑散Miconazole NitratePowder2%Johnson & Johnson Consumer B.V.未进口原研药品欧盟上市散剂81-3氢溴酸吡西替尼peficitinib hydrobromi...
2024/6/20 18:04:35
【第十批】仿制药参比制剂目录序号药品通用名称英文名称/商品名规格剂型持证商备注1备注210-1阿司匹林双嘧达莫缓释胶囊Aspirin and Dipyridamole Sustained-release Capsules/ Aggrenox阿司匹林25mg与双嘧达莫200mg胶囊剂（缓释胶囊）Boehringer Ingelheim Pharma GmbH & Co.KG欧盟上市（上市国:德国；产地：德国）10-2艾司奥美拉唑镁肠溶片Esomeprazole Magnesium Ente...
2020/8/27 16:24:40